Together we will Knock Out intestinal failure
Mission: We are devoted to raising funds for intestinal failure research, caused by Microvillus Inclusion Disease, in order to enhance the quality of life for those living with this condition.
Vision: The development of a cure to eradicate genetically caused intestinal failure that leads to secretory diarrhea.
"STAY TKO STRONG"
Vision: The development of a cure to eradicate genetically caused intestinal failure that leads to secretory diarrhea.
"STAY TKO STRONG"
About Us
Thomas Kevin Onorato was the inspiration for starting TKO STRONG FOUNDATION, INC. Thomas suffers from Microvillus Inclusion Disease. This devastating genetic disease results in intestinal failure. The rarity of this disease, and other orphan diseases, is the cause for minimal research. There is no cure for Microvillus Inclusion Disease or genetically caused intestinal failure. Therefore, we have taken the initiative to raise money to support intestinal failure research, in hope of finding a cure for all individuals living with this disease.
Officers
PRESIDENT: MARK ONORATO
VICE-PRESIDENT: WILLIAM PETERS
SECRETARY: REGINA PETERS
TREASURER: THOMAS ONORATO
VICE-PRESIDENT: WILLIAM PETERS
SECRETARY: REGINA PETERS
TREASURER: THOMAS ONORATO
Board of Directors
CO-FOUNDER & DIRECTOR: MELISSA A. KAVANAGH-ONORATO
CO-FOUNDER & DIRECTOR: THOMAS ONORATO
DIRECTOR: SAL VAGLICA
DIRECTOR: ALEXIS MERK-ONORATO
DIRECTOR: ALISON SCHWENZER
DIRECTOR: TIMOTHY CARROLL
DIRECTOR: MICHAEL FITZGERALD
DIRECTOR: KIMBERLY BARNETT-ONORATO
DIRECTOR: ANTHONY TULLO
DIRECTOR: RICHARD GUEZ
CO-FOUNDER & DIRECTOR: THOMAS ONORATO
DIRECTOR: SAL VAGLICA
DIRECTOR: ALEXIS MERK-ONORATO
DIRECTOR: ALISON SCHWENZER
DIRECTOR: TIMOTHY CARROLL
DIRECTOR: MICHAEL FITZGERALD
DIRECTOR: KIMBERLY BARNETT-ONORATO
DIRECTOR: ANTHONY TULLO
DIRECTOR: RICHARD GUEZ
Honorary Member
MAJOR CHARLES KILBRIDE
Consulting Physicians
ESI S.N. LAMOUSE-SMITH, MD, PhD
PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION
COLUMBIA UNIVERSITY MEDICAL CENTER
Dr. Lamouse-Smith received both her PhD in Immunology and MD from University of Pittsburgh School of Medicine. She completed her internship and residency in pediatrics at Morgan Stanley Children’s Hospital before pursuing a fellowship in Pediatric Gastroenterology and Nutrition at Boston Children’s Hospital. She is the recipient of the Eleanor and Miles Shore Fellowship for Scholars in Medicine from Harvard Medical School, the Harold Amos Faculty Research Development Award from the Robert Wood Johnson Foundation, and the Columbia University Provost Diversity Award. Her background and training in cellular immunology and pediatric gastroenterology has led to a specific interest in understanding the role that the gastrointestinal flora has to play on health and disease in children and the use of probiotics to manage gastrointestinal disorders in children.
JOSEPH A. PICORARO, MD
PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION
COLUMBIA UNIVERSITY MEDICAL CENTER
Dr. Picoraro received his MD from University of Pennsylvania, Perelman School of Medicine. He completed his internship and residency in pediatrics at Children's Hospital of Philadelphia before pursuing a fellowship in Pediatric Gastroenterology and Nutrition at Morgan Stanley Children's Hospital. He is investigating the application of genomic next-generation sequencing to identify the monogenic etiology of rare gastrointestinal and hepatobiliary disease phenotypes (including acute liver failure and intestinal failure).
SANDEEP WONTAKAL, MD
MOLECULAR GENETICS
COLUMBIA UNIVERSITY MEDICAL CENTER
Dr. Wontakal earned his B.A. degree in Molecular Biology & Biochemistry with minors in Philosophy and Mathematics. He later earned his M.D. and Ph.D. degrees from the Albert Einstein College of Medicine. He is currently pursuing residency training in Clinical Pathology at New York-Presbyterian Hospital- Columbia University Medical Center. At Columbia, he has helped analyze genomics data from patients' with diseases of unknown etiology. In the process, he helped identify novel mutations in known disease causing genes, as well as novel mutations in genes that were not previously associated with any disease. He hopes to utilize patient derived genomics data to help shed light on basic biological problems, which in turn have the potential to result in novel approaches to predict/diagnose/treat diseases. His particular interest is in what's referred to as "non-coding DNA" or the "dark matter of the genome".
TKO STRONG FOUNDATION, INC.
P.O. BOX 245
Malverne, NY 11565
516-887-2787
We are a non-profit article 501(c)(3) corporation
P.O. BOX 245
Malverne, NY 11565
516-887-2787
We are a non-profit article 501(c)(3) corporation
